TransMedics Group, Inc. (TMDX) Analyst Forecast

$75.63

north_east
$6.54 (9.47%)
Day's range
$71.75
Day's range
$76.57

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
12/11/2024 Robert W. Baird David Rescott $120.00 $67.36   78.15%
12/11/2024 Piper Sandler Matt O'Brien $90.00 $67.36   33.61%
10/29/2024 Robert W. Baird Joe Vruwink $150.00 $88.70   69.11%
10/29/2024 Canaccord Genuity Jason Mills $109.00 $126.24   -13.66%
10/29/2024 Needham Mike Matson $109.00 $126.24   -13.66%
10/29/2024 Oppenheimer Suraj Kalia $125.00 $126.24   -0.98%
09/23/2024 Robert W. Baird David Rescott $200.00 $159.50   25.39%
09/04/2024 Piper Sandler Matt O'Brien $180.00 $158.42   13.62%
08/21/2024 Needham Mike Matson $208.00 $166.18   25.17%
08/01/2024 Canaccord Genuity William Plovanic $169.00 $164.02   3.04%
08/01/2024 Oppenheimer Suraj Kalia $200.00 $142.26   40.59%
07/15/2024 Morgan Stanley Patrick Wood $145.00 $142.19   1.98%
07/15/2024 Piper Sandler Matt O'Brien $170.00 $142.19   19.56%
06/03/2024 Stephens George Sellers $151.00 $133.63   13%

TransMedics Group, Inc. FAQ's

TransMedics Group, Inc. has been rated by research analysts at Robert W. Baird, Piper Sandler, Canaccord Genuity, Needham, Oppenheimer, Morgan Stanley in the past 90 days.